b.coelho
Submits third-party assay reports on material purchased directly. Based in Haarlem.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
99.55%
n=6
Suppliers covered
4
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043249 | GHK-Cu | CPC | CPC-2601-D1258 | Kestrel | 2026-Q2 | 99.50 | 6.96 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042652 | CJC-1295 (no DAC) | SWB | SWB-2512-S8187 | PeptideMeter | 2026-Q1 | 98.81 | 4.13 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020954 | Semaglutide | WXT | WXT-2505-P3150 | Janoshik | 2025-Q4 | 99.60 | 4.75 | 99.1 | Supplier-supplied | 0 | PASS |
| AX-2025-020095 | Tirzepatide | SWB | SWB-2505-R8575 | Janoshik | 2025-Q2 | 98.94 | 2.31 | 91.6 | Buyer-sourced | 2 | FAIL |
| AX-2024-004534 | Hexarelin | HYB | HYB-2407-N7367 | Janoshik | 2024-Q3 | 99.93 | 4.71 | 102.5 | Buyer-sourced | 0 | PASS |
| AX-2024-004838 | PT-141 (Bremelanotide) | SWB | SWB-2311-H8764 | PeptideMeter | 2024-Q2 | 99.64 | 3.52 | 100.3 | Buyer-sourced | 1 | MARGINAL |